Cargando…

Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression

BACKGROUND: At early stages of infection CCR5 is the predominant HIV-1 coreceptor, but in approximately 50% of those infected CXCR4-using viruses emerge with disease progression. This coreceptor switch is correlated with an accelerated progression. However, those that maintain virus exclusively rest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borggren, Marie, Repits, Johanna, Kuylenstierna, Carlotta, Sterjovski, Jasminka, Churchill, Melissa J, Purcell, Damian FJ, Karlsson, Anders, Albert, Jan, Gorry, Paul R, Jansson, Marianne
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2330154/ https://www.ncbi.nlm.nih.gov/pubmed/18371209 http://dx.doi.org/10.1186/1742-4690-5-28

Ejemplares similares

Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge
por: Borggren, Marie, et al.
Publicado: (2011)

Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS
por: Sterjovski, Jasminka, et al.
Publicado: (2007)

Conformational alterations in the CD4 binding cavity of HIV-1 gp120 influencing gp120-CD4 interactions and fusogenicity of HIV-1 envelopes derived from brain and other tissues
por: Gray, Lachlan, et al.
Publicado: (2011)

Covariance of Charged Amino Acids at Positions 322 and 440 of HIV-1 Env Contributes to Coreceptor Specificity of Subtype B Viruses, and Can Be Used to Improve the Performance of V3 Sequence-Based Coreceptor Usage Prediction Algorithms
por: Cashin, Kieran, et al.
Publicado: (2014)

CoRSeq(V3-C): a novel HIV-1 subtype C specific V3 sequence based coreceptor usage prediction algorithm
por: Cashin, Kieran, et al.
Publicado: (2013)

Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection
por: Cashin, Kieran, et al.
Publicado: (2013)

Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long-term survivors infected from a single source
por: Gray, Lachlan, et al.
Publicado: (2007)

Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies
por: Chikere, Kelechi, et al.
Publicado: (2014)

DC-SIGN and L-SIGN: the SIGNs for infection
por: Khoo, Ui-Soon, et al.
Publicado: (2008)

Reduced Baseline Sensitivity to Maraviroc Inhibition Among R5 HIV-1 Isolates From Individuals With Severe Immunodeficiency
por: Karlsson, Ulf, et al.
Publicado: (2016)

Reliable Genotypic Tropism Tests for the Major HIV-1 Subtypes
por: Cashin, Kieran, et al.
Publicado: (2015)

DC-SIGN Family of Receptors
por: Gupta, Rajesh K., et al.
Publicado: (2012)

Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus Macaques
por: Borggren, Marie, et al.
Publicado: (2013)

Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection
por: Jakobsen, Martin R., et al.
Publicado: (2013)

Towards an HIV cure: science and debate from the International AIDS Society 2013 symposium
por: Purcell, Damian FJ, et al.
Publicado: (2013)

Mannose–fucose recognition by DC-SIGN
por: Geurtsen, Jeroen, et al.
Publicado: (2010)

High-Affinity Glycopolymer Binding to Human DC-SIGN and Disruption of DC-SIGN Interactions with HIV Envelope Glycoprotein
por: Becer, C. Remzi, et al.
Publicado: (2010)

Binding of DC-SIGN to the Hemagglutinin of Influenza A Viruses Supports Virus Replication in DC-SIGN Expressing Cells
por: Hillaire, Marine L. B., et al.
Publicado: (2013)

Autonomous Tetramerization Domains in the Glycan-binding Receptors DC-SIGN and DC-SIGNR
por: Yu, Quan D., et al.
Publicado: (2009)

DC-SIGN and Lung Pathogenesis in Patients with Tuberculosis
Publicado: (2005)

Pseudo-Mannosylated DC-SIGN Ligands as Immunomodulants
por: Berzi, Angela, et al.
Publicado: (2016)

Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission
por: Celerino da Silva, Ronaldo, et al.
Publicado: (2011)

The C Type Lectins DC-SIGN and L-SIGN: Receptors for Viral Glycoproteins
por: Lozach, Pierre-Yves, et al.
Publicado: (2007)

Structural Characterization of the DC-SIGN–Lewis(X) Complex
por: Pederson, Kari, et al.
Publicado: (2014)

DC/L‐SIGNs of hope in the COVID‐19 pandemic
por: Brufsky, Adam, et al.
Publicado: (2020)

Selection of DNA aptamers against DC-SIGN protein
por: Hui, Yan, et al.
Publicado: (2007)

Characterization of the duplicate L-SIGN and DC-SIGN genes in miiuy croaker and evolutionary analysis of L-SIGN in fishes
por: Shu, Chang, et al.
Publicado: (2015)

The Clinical Significance of DC-SIGN and DC-SIGNR, which Are Novel Markers Expressed in Human Colon Cancer
por: Jiang, Yanmei, et al.
Publicado: (2014)

Oligomerization domains in the glycan‐binding receptors DC‐SIGN and DC‐SIGNR: Sequence variation and stability differences
por: dos Santos, Ália, et al.
Publicado: (2016)

DC-SIGN (CD209) Promoter −336 A/G Polymorphism Is Associated with Dengue Hemorrhagic Fever and Correlated to DC-SIGN Expression and Immune Augmentation
por: Wang, Lin, et al.
Publicado: (2011)

Endocytic function is critical for influenza A virus infection via DC-SIGN and L-SIGN
por: Gillespie, Leah, et al.
Publicado: (2016)

Role of the C-type lectins DC-SIGN and L-SIGN in Leishmania interaction with host phagocytes
por: Caparrós, Esther, et al.
Publicado: (2005)

Length Variation of DC-SIGN and L-SIGN Neck-Region has no Impact on Tuberculosis Susceptibility
por: Barreiro, Luis B., et al.
Publicado: (2007)

Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function
por: Geijtenbeek, Teunis B.H., et al.
Publicado: (2003)

Rapid, directed transport of DC-SIGN clusters in the plasma membrane
por: Liu, Ping, et al.
Publicado: (2017)

Risk for HIV-1 infection is not associated with Repeat-Region polymorphism in the DC-SIGN neck domain and Novel Genetic DC-SIGN Variants among North Indians
por: Rathore, Anurag, et al.
Publicado: (2008)

Site-Selective Solid-Phase Synthesis of a CCR5 Sulfopeptide Library To Interrogate HIV Binding and Entry
por: Liu, Xuyu, et al.
Publicado: (2014)

Distinct usage of three C-type lectins by Japanese encephalitis virus: DC-SIGN, DC-SIGNR, and LSECtin
por: Shimojima, Masayuki, et al.
Publicado: (2014)

A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs
por: Borggren, Marie, et al.
Publicado: (2016)

A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations
por: Roche, Michael, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lq2tds824flg1k7lv5v99sdskl